Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 196,808 | 139,800 | 142,071 | 89,286 | 88,399 |
| Marketable Securities | 38,156 | 66,812 | 94,581 | 135,894 | 163,322 |
| Receivables | 22,497 | 18,752 | 17,887 | 17,843 | 12,881 |
| Inventories | 4,106 | 3,943 | 3,905 | 3,114 | 2,644 |
| TOTAL | $275,606 | $241,579 | $273,502 | $255,511 | $276,531 |
| Non-Current Assets | |||||
| PPE Net | 1,642 | 1,574 | 1,755 | 1,984 | 2,219 |
| Investments And Advances | 0 | 2,005 | 2,006 | 7,676 | 24,215 |
| Other Non-Current Assets | 28,057 | 8,936 | 9,304 | 9,738 | 10,085 |
| TOTAL | $29,699 | $12,515 | $13,065 | $19,398 | $36,519 |
| Total Assets | $305,305 | $254,094 | $286,567 | $274,909 | $313,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,603 | 881 | 2,309 | 3,040 | 4,450 |
| Accrued Expenses | 69,121 | 64,698 | 53,211 | 55,611 | 52,930 |
| Other current liabilities | 678 | 1,124 | 524 | 1,360 | 609 |
| TOTAL | $73,718 | $68,866 | $58,123 | $62,008 | $60,203 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 0 | 0 | N/A | 297 |
| Other Non-Current Liabilities | 311,260 | 311,205 | 311,576 | 252,541 | 202,301 |
| TOTAL | $311,260 | $311,205 | $311,576 | $252,541 | $202,301 |
| Total Liabilities | $384,978 | $380,071 | $369,699 | $314,549 | $262,504 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,280 | 5,039 | 5,036 | 5,009 | 4,978 |
| Common Shares | 8 | 8 | 8 | 8 | 7 |
| Retained earnings | -1,178,648 | -1,217,368 | -1,165,556 | -1,111,974 | -1,069,611 |
| Other shareholders' equity | 191 | 372 | 196 | 301 | 518 |
| TOTAL | $-79,673 | $-125,977 | $-83,132 | $-39,640 | $50,546 |
| Total Liabilities And Equity | $305,305 | $254,094 | $286,567 | $274,909 | $313,050 |